XELA(not low float) 9th march 2021., got a 90 million dollar contract.. Great example of why we should stay away from contract winner news when trying to short these gap ups. Due to EYES being up almost 1000% due to the FDA approval news, everyone is looking for the new 1000% runner. So they are reading the news very carefully and allowing it to basically judge whether they want to take the trade or not. So in this case BIG contract winners,FDA approvals and phase 3 trials are completely out as well. Analyze the news before even thinking of shorting. If more longs view the news as "great" well every short to put it simply will be squeezed.
Btw i didn't short XELA, i actually shorted OGEN, but was going through some stocks and reading the news and caught XELA move.
INVO was one that gapped up big and stayed green, their news was basically amendments to their commercialization deal with its US partner Ferring Pharmaceuticals to increase more INVO clinics...i think again it's because everybody is looking for the next black swan, and as soon as they see some "legit" news or at least what they think is legit, they start buying up all the supply. Low float too.
Join now or log in to leave a comment